AstraZeneca PLC

AstraZeneca PLCverified

AZN

Price:

$79.59

Market Cap:

$246.77B

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/On...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1993-05-12

Stock Exchange

NASDAQ

Ticker

AZN

The ROE as of June 2024 (TTM) for AstraZeneca PLC (AZN) is 16.75%

According to AstraZeneca PLC’s latest financial reports and current stock price. The company's current ROE is 16.75%. This represents a change of 298.18% compared to the average of 4.21% of the last 4 quarters.

AstraZeneca PLC (AZN) Historical ROE (quarterly & annually)

How has AZN ROE performed in the past?

The mean historical ROE of AstraZeneca PLC over the last ten years is 13.75%. The current 16.75% ROE has changed 21.86% with respect to the historical average. Over the past ten years (40 quarters), AZN's ROE was at its highest in in the December 2016 quarter at 12.40%. The ROE was at its lowest in in the September 2021 quarter at -4.16%.

Quarterly (TTM)
Annual

Average

13.75%

Median

15.25%

Minimum

0.29%

Maximum

23.56%

AstraZeneca PLC (AZN) ROE by Quarter and Year

Discovering the peaks and valleys of AstraZeneca PLC ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.01%

Maximum Annual ROE = 23.56%

Minimum Annual Increase = -98.61%

Minimum Annual ROE = 0.29%

Quarterly (TTM)
Annual
YearROEChange
202315.21%71.37%
20228.88%3.01%
20210.29%-98.61%
202020.46%101.17%
201910.17%-41.16%
201817.28%-13.84%
201720.06%-14.84%
201623.56%54.18%
201515.28%143.20%
20146.28%-42.92%

AstraZeneca PLC (AZN) Average ROE

How has AZN ROE performed in the past?

The current ROE of AstraZeneca PLC (AZN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

8.13%

5-year avg

11.00%

10-year avg

13.75%

AstraZeneca PLC (AZN) ROE vs. Peers

How is AZN’s ROE compared to its peers?

AstraZeneca PLC’s ROE is less than Novartis AG (34.58%), less than GSK plc (33.83%), less than Roche Holding AG (61.78%), greater than Bristol-Myers Squibb Company (-23.01%), less than Sanofi (9.61%), less than Merck & Co., Inc. (5.84%), less than Gilead Sciences, Inc. (2.32%), less than Johnson & Johnson (53.97%), less than AbbVie Inc. (55.33%), less than Eli Lilly and Company (53.53%), greater than Pfizer Inc. (-0.31%), less than Amgen Inc. (58.59%),

CompanyROEMarket cap
34.58%$206.84B
33.83%$82.89B
61.78%$223.99B
-23.01%$83.52B
9.61%$115.89B
5.84%$327.95B
2.32%$81.06B
53.97%$350.27B
55.33%$297.71B
53.53%$834.88B
-0.31%$156.00B
58.59%$160.19B

Build a custom stock screener for AstraZeneca PLC (AZN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AstraZeneca PLC using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AstraZeneca PLC (AZN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AstraZeneca PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is AstraZeneca PLC's ROE?

How is the ROE calculated for AstraZeneca PLC (AZN)?

What is the highest ROE for AstraZeneca PLC (AZN)?

What is the 3-year average ROE for AstraZeneca PLC (AZN)?

What is the 5-year average ROE for AstraZeneca PLC (AZN)?

How does the current ROE for AstraZeneca PLC (AZN) compare to its historical average?